VIVEVE MEDICAL, INC. VIVE Income Statement

Viveve medical, inc. (VIVE)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Revenue
1,304	1,451	1,052	1,052	3,012	4,472	4,821	5,525	3,699	-	4,070	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue
-	-	-	-	-	-	-	-	-	-	-	3,076	3,041	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	2,452	1,849	1,556	1,284	752	584	73	38	-	17	73	-	-572	4	372	348	485	212	363	20	189	27	398	57
Cost of revenue
1,129	1,570	1,099	941	1,941	2,807	3,327	2,711	2,352	2,329	2,059	1,837	1,619	1,496	1,158	1,022	936	465	417	53	50	8	15	24	3	-133	1	135	179	233	84	211	13	71	17	198	140
Gross profit
175	-119	-47	111	1,071	1,665	1,494	2,814	1,347	2,772	2,011	1,239	1,422	956	691	534	348	287	167	20	-12	-8	2	49	-3	-439	3	237	169	252	128	152	7	118	10	200	-83
Operating expenses:
Research and development
1,637	1,759	1,449	2,902	2,480	2,746	3,442	3,672	3,756	3,051	3,464	3,440	2,388	2,052	2,054	2,463	1,796	1,542	1,515	1,086	845	231	573	428	194	-517	177	558	554	413	549	554	515	454	312	373	73
Selling, general and administrative
4,365	5,175	5,032	5,530	6,626	11,187	9,114	9,437	8,931	9,150	7,369	6,862	5,450	4,433	3,272	2,615	2,548	2,309	1,757	1,821	1,577	896	1,789	812	779	946	532	965	685	734	674	564	661	594	591	667	593
Restructuring costs
-	0	0	0	742	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
6,002	6,934	6,481	8,432	9,848	13,933	12,556	13,109	12,687	12,201	10,833	10,302	7,838	6,485	5,326	5,078	4,344	3,851	3,272	2,907	2,422	1,127	2,362	1,240	973	429	709	1,523	1,239	1,147	1,223	1,118	1,176	1,048	903	1,040	666
Loss from operations
-5,827	-7,053	-6,528	-8,321	-8,777	-12,268	-11,062	-10,295	-11,340	-9,429	-8,822	-9,063	-6,416	-5,529	-4,635	-4,544	-3,996	-3,564	-3,105	-2,887	-2,434	-1,135	-2,360	-1,191	-976	-868	-706	-1,286	-1,070	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	4	-	-	-	-	-	-	-	-
Gain on the sale of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	40	-
Loss from operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,095	-966	-1,169	-930	-893	-800	-749
Interest expense, net
210	835	1,209	1,194	1,116	1,133	1,106	1,063	1,070	784	777	1,345	263	276	221	765	108	113	114	105	83	168	152	71	176	89	156	61	140	186	137	116	116	119	116	115	46
Other expense, net
-91	-28	-51	-71	-11	27	-4	0	-10	-11	-16	-17	-16	-15	-13	-7	-2	0	0	-14	-7	-1	8	21	21	-	-8	-	-	-	-	-	-	-	-	-	-
Net loss from consolidated companies
-6,128	-14,621	-7,788	-9,586	-9,904	-13,374	-12,172	-11,358	-12,420	-10,224	-9,615	-10,425	-6,695	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,029	-401	-541	-5,019
Loss from minority interest in limited liability company
-182	-196	-168	-138	-125	-	-132	-158	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from minority interest in limited liability company
-	-	-	-	-	-	-	-	249	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign currency transaction gains (losses)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	-	-	-	3	-8	12	17	-28	13	-	-	-	-
Financing costs associated with convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	530
Change in fair value of warrant and option liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,873	-	-	-	6,113	-3,999	-	-	-	-	64	232	372	-1,476
Financing costs associated with convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	80	-	-	-	-	-	-
Change in fair value of warrant and option liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,117	0	-2,400	-	-	-	-
Change in fair value of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	711	-	-	-	3,177	-1,312	2,194	-757	-354	-3,107	-54	376	2	-2,218
Loss on extinguishment of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1,283	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	20	-	-	-	-	-
Total other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,520	-	-	-	9,232	-6,738	3,896	-2,070	-478	-5,610	-99	492	259	-4,270
Comprehensive and net loss
-6,310	-14,817	-7,956	-9,724	-10,029	-13,492	-12,304	-11,516	-12,669	-10,224	-9,615	-10,425	-6,695	-5,820	-4,869	-5,316	-4,106	-3,677	-3,219	-3,006	-2,524	-4,874	-2,504	2,329	-1,131	-3,583	-871	7,946	-7,808	-	-	-	-	-	-	-	-
Series B convertible preferred stock dividends
989	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Benefit for income taxes from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-492
Net loss from continuing operations, net of income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,029	-401	-541	-4,527
Income from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	53
Gain on sale of discontinued operations, net of provision for income taxes of $492
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	687
Net income from discontinued operations, net of income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	740
Net loss attributable to common stockholders
-7,299	-	-	-	-10,029	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,001	-3,165	-1,444	-6,779	-1,029	-401	-541	-3,787
Net loss per share of common stock:
From loss on continuing operations attributable to common stockholders (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.02	-0.01	-0.02	-0.16
From income on discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00
From gain on sale of discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	-0.02	0.04
Basic and diluted (in dollars per share)
-0.82	0.96	-13.51	-0.21	-21.63	-120.99	-39.07	-0.37	-0.49	-0.50	-0.50	-0.54	-0.57	-0.51	-0.46	-0.66	-0.55	-0.20	-0.50	-0.67	-1.10	37.12	-1.76	-15.20	-21.43	-	-0.23	-	-	-	-	-	-0.22	-0.04	-0.01	-0.02	-0.12
Weighted average shares used in computing net loss per common share:
Basic and diluted (in shares)
8,930	-42,555	588	46,494	463	-56,224	314	31,305	25,846	19,541	19,408	19,373	11,663	10,685	10,630	8,080	7,493	6,926	6,418	4,454	2,293	17,937	1,419	52	52	-	3,743	-	41,670	-	-	-	30,357	-	-	-	-
Net loss per weighted average share, basic (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	0.12	-0.19	-	-0.10	-0.05	-	-	-	-	-
Net loss per weighted average share, diluted (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	0.01	-	-	-	-	-	-	-	-	-
Basic (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	135,093	-	-	-	63,922	-	-	30,397	30,983	-	-90,931	30,351	30,351	30,351
Diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	288,092	-	-	-	137,764	-	-	-	-	-	-	30,351	30,351	-